NCT00895895 Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease Status TERMINATED Phase PHASE2
NCT00895583 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Status COMPLETED Phase PHASE4
NCT00895050 Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients Status COMPLETED Phase N/A
NCT00894686 Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) Status COMPLETED Phase PHASE4
NCT00894660 A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00894374 Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00891397 Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) Status TERMINATED Phase NA
NCT00889720 A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery Status COMPLETED Phase PHASE4
NCT00888576 Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan Status COMPLETED Phase N/A
NCT00887575 Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00887224 Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00886821 A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics Status COMPLETED Phase PHASE1
NCT00886743 Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia Status TERMINATED Phase PHASE2
NCT00886093 A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT00884676 Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00884390 Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings Status TERMINATED Phase PHASE4
NCT00883896 Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00880854 Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer Status WITHDRAWN Phase PHASE1